Neonatal Screening for Critical Congenital Heart Disease

Congenital heart disease (CHD) affects the structure and function of the heart and blood vessels present at birth. Some defects are mild and discovered during routine follow-up, while critical congenital heart disease (CCHD) can cause severe circulatory collapse during the first days of life. Early recognition is therefore a central responsibility of newborn care.

Pulse oximetry screening offers a fast, non-invasive way to identify babies whose oxygen saturation is unexpectedly low. It does not replace antenatal ultrasound, a careful physical examination, or diagnostic echocardiography. Instead, it adds a practical safety net before a newborn leaves a hospital or birthing facility.

The subject sits within the wider field of perinatal and neonatal medicine represented by the FAOPS 2020 archive, which documented a planned scientific meeting in Tokyo focused on research and clinical practice across Asian and Oceanian perinatal societies. Screening programs benefit from this same international perspective because disease prevalence, equipment, referral systems, and birth settings vary widely between regions.

Why Early Detection Matters

Critical heart defects may obstruct blood flow, limit mixing between oxygenated and deoxygenated blood, or interfere with the heart’s ability to support the lungs and body. A newborn can appear comfortable for several hours while the ductus arteriosus remains open. As that fetal connection begins to close, symptoms such as cyanosis, rapid breathing, poor feeding, weak pulses, lethargy, or shock may develop quickly.

A routine examination can miss serious disease. Cyanosis is sometimes subtle, especially under artificial lighting, and heart murmurs may be absent or difficult to hear. Pulse oximetry measures the percentage of hemoglobin carrying oxygen, creating an objective physiological signal that can prompt further assessment.

The purpose of screening is earlier clinical action, not automatic diagnosis. A low reading may result from CCHD, but it can also reflect respiratory disease, infection, pulmonary hypertension, hypothermia, poor circulation, or technical error. Every failed screen requires a structured evaluation rather than an assumption about the cause.

How Pulse Oximetry Screening Works

Most established protocols test healthy-appearing newborns after 24 hours of age, or as late as possible before discharge when early discharge is unavoidable. Measurements are taken from the right hand, representing preductal circulation, and from either foot, representing postductal circulation. The infant should be warm, settled, and receiving reliable signal detection.

A common algorithm considers a screen positive when saturation is below 90% in either site, when repeated readings remain below a defined threshold, or when there is a persistent difference between the hand and foot. Exact cutoffs and repeat intervals vary by national guidance and local resources. Facilities should adopt one validated protocol and train staff to apply it consistently.

The device must be suitable for neonatal use and capable of detecting motion and low-perfusion conditions. A poorly placed sensor, cold extremity, movement, ambient light, or an unstable waveform can produce misleading results. Staff should document the preductal and postductal values, the infant’s age, the time of measurement, and any symptoms or oxygen therapy.

Interpreting Results And Acting Safely

A normal result lowers the likelihood of certain critical defects, but it cannot exclude every form of CHD. Lesions that do not cause hypoxemia, including some coarctations of the aorta, may pass screening. A normal saturation reading also does not eliminate the need for examination, family history assessment, and attention to feeding, perfusion, pulses, and respiratory status.

An abnormal result should trigger immediate clinical review. The first steps commonly include confirming sensor placement and signal quality, repeating measurements according to protocol, and assessing temperature, breathing, perfusion, blood glucose, and signs of infection. If hypoxemia persists, the infant needs timely evaluation by a clinician experienced in neonatal care, with echocardiography arranged when indicated.

Oxygen should not be used simply to make the number appear normal while delaying investigation. The clinical team must consider ductal-dependent circulation, pulmonary disease, sepsis, and persistent pulmonary hypertension. Stabilization may require respiratory support, intravenous access, prostaglandin E1, transport to a specialist center, or consultation with pediatric cardiology.

Building A Reliable Screening Program

A successful program depends on workflow as much as equipment. Screening responsibility should be assigned before birth, and every staff member involved should know when the test occurs, where results are recorded, and who receives an abnormal result. Electronic records can support reminders, but a clear paper process is still valuable where digital systems are limited.

Hospitals should track the number of eligible newborns screened, failed screens, repeat tests, transfers, confirmed diagnoses, and missed cases. Reviewing false-positive results helps identify problems such as testing too soon after birth or inconsistent technique. Reviewing false-negative cases can reveal defects in the protocol, gaps in examination, or delays in recognizing symptoms after discharge.

Parents need a simple explanation of the test and its limits. They should understand that a sensor placed on the hand and foot may lead to additional examinations, and that referral does not mean a heart defect has been confirmed. Discharge information should describe warning signs such as bluish color, fast or difficult breathing, sweating or tiring during feeds, unusual sleepiness, and reduced urine output.

Resource planning is especially important in rural and regional settings. Screening is valuable only when a failed result can lead to assessment, stabilization, echocardiography, and safe transport. A facility should define referral contacts, emergency transport arrangements, oxygen and medication availability, and communication procedures before launching a screening initiative.

Limitations And Equity Considerations

Pulse oximetry is less effective for defects that do not cause low oxygen saturation during the newborn period. It also cannot identify every genetic syndrome, valve abnormality, rhythm disorder, or evolving obstruction. A baby who passes the screen still needs routine pediatric surveillance and rapid review if symptoms appear.

False-positive results can increase parental anxiety, testing costs, and transfers, particularly when screening is performed during the first hours of life. Using an accepted timing strategy and repeating borderline readings can improve specificity. Conversely, excessively loose thresholds or skipped screens may delay care for a baby with serious disease.

Skin pigmentation, altitude, climate, and local disease patterns can affect interpretation and implementation. Equipment procurement should include neonatal probes, maintenance plans, battery access, and staff competency checks. Programs should be evaluated using local data rather than assuming that a protocol developed in a different health system will work unchanged.

Broader maternal and newborn health priorities also shape screening outcomes. Conditions such as HIV exposure, prematurity, infection, and limited access to antenatal care may compete for attention in the same clinical setting. The perinatal HIV discussion illustrates how screening and prevention programs must be connected to durable systems of follow-up, treatment, and family support.

Recommendations For Clinical Teams

• Test eligible newborns at the recommended age using a validated neonatal pulse oximeter and a consistent hand-and-foot protocol.
• Confirm borderline or technically unreliable readings before labeling a screen abnormal.
• Treat persistent low saturation as a medical concern requiring examination, stabilization, and an appropriate referral pathway.
• Combine pulse oximetry with antenatal assessment, physical examination, pulse checks, feeding observation, and post-discharge safety-netting.
• Audit screening coverage, failed screens, confirmed diagnoses, transfers, and missed cases at regular clinical governance meetings.

Making Screening Part Of Newborn Care

Neonatal pulse oximetry screening is most effective when it becomes a dependable part of the birth-to-discharge pathway rather than an isolated measurement. Clear protocols, trained staff, functioning devices, rapid interpretation, and specialist referral must work together. Families should leave with understandable information and a realistic plan for urgent review if symptoms emerge.

Clinical leaders can begin by mapping the current newborn journey, identifying where screening is missed, and confirming how an abnormal result will be managed at every hour of the day. Use local audit data to refine the process, strengthen referral links, and ensure that every baby with suspected critical heart disease receives timely assessment and care.